Randomized, controlled trials have shown both benefit and harm from tight blood-glucose control in patients in the intensive care unit (ICU). Variation in the use of early parenteral nutrition and in ...

Researchers investigated the role of glucose control on multiple cardiovascular disease-related events in patients with type 2 diabetes. Glucose control intensity does not affect macrovascular risk in ...

Whether blood sugar spikes or drops suddenly, patients with diabetes should be armed with an understanding of what to do.

Patients randomized to an intensive control target of 90-130 mg/dL ended up with a similar mean glucose compared with those assigned a standard 140-180 mg/dL treatment target (170 vs 175 mg/dL, P=0.25 ...

In a recent study published in Nature, researchers report the design and experimental efficacies of NNC2215, a novel insulin conjugate comprising synthetically added glucose-binding macrocycles and ...

Expert Rev Endocrinol Metab. 2008;3(6):691-697. Elimination of sitagliptin occurs primarily via renal excretion (79%) and involves active tubular secretion. Sitagliptin is a substrate for human ...

Intensive management of diabetes pays fewer dividends as patients age and raises the chances of hypoglycemia. But many people have not gotten the message. By Paula Span By now, Ora Larson recognizes ...

Artificial pancreas technology improved blood glucose control in young children between ages 2 and 5 with type 1 diabetes, according to the results of the Pediatric Artificial Pancreas (PEDAP) Trial, ...